Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 13, 2008 - Issue 3
Submit an article Journal homepage
195
Views
23
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for adrenocortical carcinoma

Alfredo Berruti University of Turin, Department of Clinical and Biological Science, Oncologia Medica, Azienda Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy +39 0119026512; +39 0119026992; [email protected]
,
Anna Ferrero University of Turin, Department of Clinical and Biological Science, Oncologia Medica, Azienda Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy +39 0119026512; +39 0119026992; [email protected]
,
Paola Sperone University of Turin, Department of Clinical and Biological Science, Oncologia Medica, Azienda Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy +39 0119026512; +39 0119026992; [email protected]
,
Fulvia Daffara Medicina Interna, Azienda Ospedaliera San Luigi Gonzaga, Orbassano, Italy +39 0119026427; +39 0119026992; [email protected]
,
Giuseppe Reimondo Medicina Interna, Azienda Ospedaliera San Luigi Gonzaga, Orbassano, Italy +39 0119026427; +39 0119026992; [email protected]
,
Mauro Papotti Anatomia Patologica, Azienda Ospedaliera San Luigi Gonzaga, Orbassano, Italy +39 0119026486; +39 0119026992; [email protected]
,
Luigi Dogliotti University of Turin, Department of Clinical and Biological Science, Oncologia Medica, Azienda Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy +39 0119026512; +39 0119026992; [email protected]
,
Alberto Angeli Medicina Interna, Azienda Ospedaliera San Luigi Gonzaga, Orbassano, Italy +39 0119026427; +39 0119026992; [email protected]
&
Massimo Terzolo Medicina Interna, Azienda Ospedaliera San Luigi Gonzaga, Orbassano, Italy +39 0119026427; +39 0119026992; [email protected]
 show all
Pages 497-509 | Published online: 02 Sep 2008

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Valentina Cremaschi, Andrea Abate, Deborah Cosentini, Salvatore Grisanti, Elisa Rossini, Marta Laganà, Mariangela Tamburello, Antonella Turla, Sandra Sigala & Alfredo Berruti. (2022) Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art?. Expert Opinion on Pharmacotherapy 23:12, pages 1413-1424.
Read now
Cristina E Tognon & Poul HB Sorensen. (2012) Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Expert Opinion on Therapeutic Targets 16:1, pages 33-48.
Read now

Articles from other publishers (21)

Cécile Picard, Cécile Faure‐Conter, Pierre Leblond, Laurence Brugières, Cécile Thomas‐Teinturier, Frédéric Hameury, Anne‐Sophie Defachelles, Arnauld Verschuur, Hervé J Brisse, Sabine Sarnacki, Frédérique Dijoud, Yves Reguerre, Pascal Chastagner, Matthieu Carton & Daniel Orbach. (2019) Exploring heterogeneity of adrenal cortical tumors in children: The French pediatric rare tumor group (Fracture) experience. Pediatric Blood & Cancer 67:2.
Crossref
Martina Fragni, Lilian Patricia Palma Lopez, Elisa Rossini, Andrea Abate, Deborah Cosentini, Valentina Salvi, Sara Vezzoli, Pietro Luigi Poliani, Daniela Bosisio, Constanze Hantel, Guido A.M. Tiberio, Salvatore Grisanti, Maurizio Memo, Massimo Terzolo, Alfredo Berruti & Sandra Sigala. (2019) In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆. Molecular and Cellular Endocrinology 498, pages 110585.
Crossref
Sara G. Creemers, Leo J. Hofland & Richard A. Feelders. 2017. Management of Adrenal Masses in Children and Adults. Management of Adrenal Masses in Children and Adults 225 243 .
J S Ross, K Wang, J V Rand, L Gay, M J Presta, C E Sheehan, S M Ali, J A Elvin, E Labrecque, C Hiemstra, J Buell, G A Otto, R Yelensky, D Lipson, D Morosini, J Chmielecki, V A Miller & P J Stephens. (2014) Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies. Journal of Clinical Pathology 67:11, pages 968-973.
Crossref
Yunze Xu, Yicheng Qi, Yu Zhu, Guang Ning & Yiran Huang. (2014) Molecular markers and targeted therapies for adrenocortical carcinoma. Clinical Endocrinology 80:2, pages 159-168.
Crossref
Jennifer LaFemina & Murray F. Brennan. (2012) Adrenocortical carcinoma: Past, present, and future. Journal of Surgical Oncology 106:5, pages 586-594.
Crossref
Adrienn Zsippai, Diana Rita Szabó, Zsófia Tömböl, Peter M Szabó, Katalin Éder, Éva Pállinger, Rolf C Gaillard, Attila Patócs, Sára Tóth, András Falus, Károly Rácz & Peter Igaz. (2012) Effects of mitotane on gene expression in the adrenocortical cell line NCI-H295R: a microarray study. Pharmacogenomics 13:12, pages 1351-1361.
Crossref
Martin Fassnacht, Massimo Terzolo, Bruno Allolio, Eric Baudin, Harm Haak, Alfredo Berruti, Staffan Welin, Carmen Schade-Brittinger, Andr? Lacroix, Barbara Jarzab, Halfdan Sorbye, David J. Torpy, Vinzenz Stepan, David E. Schteingart, Wiebke Arlt, Matthias Kroiss, Sophie Leboulleux, Paola Sperone, Anders Sundin, Ilse Hermsen, Stefanie Hahner, Holger S. Willenberg, Antoine Tabarin, Marcus Quinkler, Christelle de la Fouchardi?re, Martin Schlumberger, Franco Mantero, Dirk Weismann, Felix Beuschlein, Hans Gelderblom, Hanneke Wilmink, Monica Sender, Maureen Edgerly, Werner Kenn, Tito Fojo, Hans-Helge M?ller & Britt Skogseid. (2012) Combination Chemotherapy in Advanced Adrenocortical Carcinoma. New England Journal of Medicine 366:23, pages 2189-2197.
Crossref
A. Berruti, P. Sperone, A. Ferrero, A. Germano, A. Ardito, A. M. Priola, S. De Francia, M. Volante, F. Daffara, D. Generali, S. Leboulleux, P. Perotti, E. Baudin, M. Papotti & M. Terzolo. (2011) Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. European Journal of Endocrinology 166:3, pages 451-458.
Crossref
Stefanie Hahner, Michael C. Kreissl, Martin Fassnacht, Heribert Haenscheid, Pascal Knoedler, Katharina Lang, Andreas K. Buck, Christoph Reiners, Bruno Allolio & Andreas Schirbel. (2012) [131I]Iodometomidate for Targeted Radionuclide Therapy of Advanced Adrenocortical Carcinoma. The Journal of Clinical Endocrinology & Metabolism 97:3, pages 914-922.
Crossref
Amir H. Lebastchi, John W. Kunstman & Tobias Carling. (2012) Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art. Journal of Oncology 2012, pages 1-11.
Crossref
Jan op den Winkel, Joachim Pfannschmidt, Thomas Muley, Christiane Grünewald, Hendrik Dienemann, Martin Fassnacht & Bruno Allolio. (2011) Metastatic Adrenocortical Carcinoma: Results of 56 Pulmonary Metastasectomies in 24 Patients. The Annals of Thoracic Surgery 92:6, pages 1965-1970.
Crossref
Alfredo Berruti, Paola Sperone, Elisa Bellini, Fulvia Daffara, Paola Perotti, Arianna Ardito, Andrea Saini & Massimo Terzolo. (2011) Metronomic Therapy Concepts in the Management of Adrenocortical Carcinoma. Hormones and Cancer 2:6, pages 378-384.
Crossref
Matthias Kroiss, Marcus Quinkler, Werner K. Lutz, Bruno Allolio & Martin Fassnacht. (2011) Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma. Clinical Endocrinology 75:5, pages 585-591.
Crossref
Martin Fassnacht, Rossella Libé, Matthias Kroiss & Bruno Allolio. (2011) Adrenocortical carcinoma: a clinician's update. Nature Reviews Endocrinology 7:6, pages 323-335.
Crossref
Lyndal J. Tacon, Ruth S. PrichardPatsy S. H. Soon, Bruce G. Robinson, Roderick J. Clifton-Bligh & Stan B. Sidhu. (2011) Current and Emerging Therapies for Advanced Adrenocortical Carcinoma. The Oncologist 16:1, pages 36-48.
Crossref
Charles Butler, William M. Butler & Ali A. Rizvi. (2010) Sustained Remission with the Kinase Inhibitor Sorafenib in Stage IV Metastatic Adrenocortical Carcinoma. Endocrine Practice 16:3, pages 441-445.
Crossref
Francesco Cavagnini & Francesca Pecori Giraldi. 2010. Endocrinology. Endocrinology 1864 1896 .
Mabrouka Doghman, Julie Cazareth, Dominique Douguet, Franck Madoux, Peter Hodder & Enzo Lalli. (2009) Inhibition of Adrenocortical Carcinoma Cell Proliferation by Steroidogenic Factor-1 Inverse Agonists. The Journal of Clinical Endocrinology & Metabolism 94:6, pages 2178-2183.
Crossref
M. Doghman & E. Lalli. (2009) A matter of dosage: SF-1 in adrenocortical development and cancer. Annales d'Endocrinologie 70:3, pages 148-152.
Crossref
Aaron Sabolch & Edgar Ben-Josef. 2011. Adrenocortical Carcinoma. Adrenocortical Carcinoma 427 441 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.